We Searched a Wearable Glucose Monitor Idea for Prior Art — Here's What We Found
The idea submitted to Patent Gnome:
A wearable biometric patch that continuously monitors blood glucose through the skin using near-infrared light sensors — no needles. It transmits data to a smartphone via Bluetooth and triggers an audible alert if levels fall outside a pre-configured safe range.
A clean pitch. The problem is real: hundreds of millions of people managing diabetes deal daily with the discomfort of finger-prick testing. The technology direction — optical, non-invasive — is well-established in consumer health hardware. And on the surface, the product sounds specific enough to feel novel.
Patent Gnome scanned 200 patents. Four came back RED.
What RED means, before anything else
A RED signal means a specific independent claim in an existing patent covers the core mechanism of an idea closely enough that building it today would likely constitute infringement. It doesn’t automatically end the project. But it means you need to understand exactly what’s claimed — and why — before committing serious money to development.
The four collisions
US2017164878A1 — Wearable Technology for Non-Invasive Glucose Monitoring
The most direct hit. This patent describes a wearable device that uses electromagnetic energy emitters and receivers to monitor glucose non-invasively. That’s the mechanism: NIR emitters send light into skin tissue, receivers detect the reflected signal, and processing derives glucose concentration. The device type is the same. The core physical mechanism is the same. There’s no structural delta to argue.
WO2024173947A1 — Health Sensor Using Multiple Light Emitting Diodes
Filed in 2024. It covers a non-invasive continuous biometric sensor using Near Infrared Spectroscopy — photoemitters and photoreceivers — for determining biomolecule concentration, explicitly including glucose. The language maps directly to the NIR patch. Notably, this patent is recent enough to still be in prosecution, which means the assignee’s legal team is actively defining and defending its scope right now.
WO2025166022A1 — Multimodal Physiological Monitoring System
Filed in 2025, which means the space isn’t just historically covered — it’s still being actively claimed. Claim 1 describes a wearable physiological monitoring system with optical sensors. Claim 2 explicitly includes near-infrared light. Claim 7 adds a flexible adhesive patch form factor. The progression through those claims traces the original idea almost exactly: NIR optical sensing, wearable, adhesive patch, data transmission. Landing inside a claim tree this precisely is not an ambiguous result.
US2018214088A1 — System and Method for Obtaining Health Data Using a Neural Network
Different in character from the first three, but equally blocking. Claim 1 covers a device using light reflected from skin tissue — including infrared wavelengths — to determine glucose concentration. The auditor’s note on this one is worth reading carefully: “Adding Bluetooth alerts does not create a structural delta.”
This is one of the most common misunderstandings about how patents actually work. A founder adds a feature — smartphone sync, cloud alerts, AI-based trend prediction — and assumes the addition distinguishes their product. It doesn’t, when the underlying mechanism is already claimed. Patents protect mechanisms, not full product configurations. The alert system is invisible to the infringement analysis; the NIR-through-skin approach is what matters.
What the two GREEN results reveal
Two patents returned GREEN — not safe, but contextual. They’re worth reading because they show exactly where the NIR approach isn’t a problem.
WO2026080527A1 — Health Information Based on Wearable Sensors
This patent predicts glucose state using heart rate and heart rate variability data, not optical sensing. The mechanism is correlation-based physiological modeling — no light through skin at all. GREEN here means that a wearable predicting glucose from HR/HRV would have a clear structural separation from all four RED patents.
WO2026079566A1 — Method and Apparatus for Analyzing Glucose Level of a Person
Same logic, different route: this patent determines glucose using electrical parameters — bioimpedance. An electrochemical sensing approach rather than an optical one. Same outcome, fundamentally different mechanism. Again, GREEN.
What this actually tells you
The four RED signals converge on one conclusion: near-infrared optical sensing for non-invasive wearable glucose monitoring is claimed thoroughly, from multiple directions, by multiple parties, across multiple jurisdictions. The mechanism is blocked.
The two GREEN signals say the same thing from the other side: the white space is in the mechanism, not the goal. Continuous non-invasive glucose monitoring on a wearable, delivered to a smartphone — that product isn’t blocked. The specific physical approach of using NIR light through skin tissue to derive glucose concentration is.
An inventor sitting with this result has real paths forward. HR/HRV-based glucose prediction. Bioimpedance sensing. A claims-level legal review to find whether a specific implementation might escape the language of one or more of the four RED patents — that path is expensive and genuinely uncertain, but it isn’t necessarily closed. What the prior art search does is make the decision legible before the development budget is committed.